http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-735321-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
filingDate 1952-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1955-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-735321-A
titleOfInvention Process for the preparation of 3-keto-bis-nor-4-cholen-22-al
abstract 3 - Keto - bisnor - 4 - cholen - 22 - al is prepared by selectively ozonizing the 22-double bond of 4 : 22 - ergostadien - 3 - one, without concurrently ozonizing the 4-double bond thereof, to produce 4 : 22 - ergostadien - 3-one - 22(23) - mono - ozonide, and reductively decomposing said ozonide. The required 4 : 22-ergostadien - 3 - one is obtained by selective hydrogenation of 4 : 6 : 22-ergostatrien-3-one in the presence of a palladium catalyst. Specified solvents for the ozonization are chloroform, carbon tetrachloride, ether, methanol, ethyl acetate, acetic acid and methylene chloride, and the reaction is preferably effected in the presence of an acid-binding agent, e.g. pyridine picoline, triethylamine or N-methyl piperidine. In an example 4 : 6 : 22-ergostatrien-3-one is hydrogenated in methanol containing potassium hydroxide, using a palladium-charcoal catalyst, and the resultant 4 : 6-ergostadiene-3-one ozonized in methylene chloride containing pyridine to yield the mono-ozonide, which is decomposed with zinc dust and acetic acid to yield 3-keto-bisnor-4-cholen-22-al. Specification 679,775 is referred to.
priorityDate 1952-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19753594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57475673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448379541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22955401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425755001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447629949

Total number of triples: 46.